GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn Pharma Pharma giant GSK has sealed a $10bn deal to snap up Boston-based biopharmaceutical company Nuvalent. The FTSE 100 titan said it will pay $124 per share in cash in the agreement, marking a 40 per cent premium over what Nuvalent’s stock was trading at just before this announcement. The deal is expected to officially close [...]
UK in line for fresh US tariff hit as Trump proposes ‘forced labour’ levy Economics Donald Trump has proposed a fresh round of tariffs that would hit numerous nations including the UK as the President seeks to rebuild his sweeping wall of levies that were struck down by the Supreme Court. The US is exploring a tariff of at least ten per cent on imports from up to 60 trading [...]
FTSE 100 Live: Stocks take a dip amid tariff turmoil; Oil price soars Markets Good morning and welcome back to the Morning Wire liveblog. The good old safety net of London’s blue-chip index strikes again. The week kicked off with more tariff drama after Saturday’s announcement from President Donald Trump of a sweeping 15 per cent levy across the US’ trading partners. As cool heads prevailed in government – [...]
FTSE 100 Live: Stocks jittery after Trump tariffs; Job vacancies fall February 23, 2026 Good morning and welcome back to the Morning Wire liveblog. Tariffs are once more redefining market sentiment. Last Friday, a number of FTSE 100 stocks popped on the news President Donald Trump’s ‘Liberation Day’ levies had been struck down by the US Supreme Court. It marked a major boost to global markets after the top [...]
UK and Trump in new tariff discussions as businesses sound alarm February 22, 2026 The UK is in discussions with the US over President Trump’s latest tariff salvo, a cabinet minister has confirmed, as businesses sound the alarm about the increased rate. President Donald Trump raised his base global tariff rate to 15 per cent on Saturday after the US Supreme Court struck down the authority he used to [...]
FTSE 100 Live: Trump to rock davos; Stocks dip after inflation January 21, 2026 Good morning and welcome back to the Morning Wire liveblog. Inflation spiked above expectations this morning, coming in at 3.4 per cent, according to fresh figures from the Office for National Statistics (ONS). This soared above a poll of economists by Bloomberg expecting 3.3 per cent. “Inflation ticked up a little in December, driven partly [...]
FTSE 100 and Wall St sink as EU and Trump war of words heats up January 20, 2026 The war of words between the Trump administration and Europe ramped up on Tuesday as world leaders headed for a showdown in Davos whilst global markets sunk into the red. Ursula Von der Leyen, the president of the European Commission, said the tariffs imposed on European nations due to their staunch defence of Greenland’s sovereignty [...]
GSK strikes deal to cut drug prices with US government December 22, 2025 GSK has struck a voluntary agreement with the US government to lower the cost of prescription medicines and expand access to treatments for millions of Americans. The move comes as pressure mounts on global drugmakers over pricing, tariffs, and domestic investment. The London-listed pharma giant said the deal covers medicines used by over 40m US [...]
Hikma: FTSE 100 giant’s boss replaced by former chief after share price woes December 15, 2025 The boss of FTSE 100 giant Hikma Pharmaceuticals will be replaced by the firm’s former top chief after the group’s share price dropped by nearly a quarter this year. Riad Mishlawi has exited his role as chief executive at Hikma, with executive chairman Said Darwazah to step into the post with “immediate effect”. It ends [...]
GSK shares jump as profit upgrade defies tariff gloom October 29, 2025 Shares in GSK climbed as much as three per cent to 1,705p on Wednesday morning as the pharma giant defied tariff fears with an upgrade to its profit guidance. The London-based business said it now expects turnover to increase by six to seven per cent for the full year 2025, up from its previous guidance [...]